[ad_1]
Purdue Pharma filed a bankruptcy plan on Monday that would resolve thousands of opioid lawsuits by restructuring the OxyContin maker into an entity that would steer profits to plaintiffs and require the company’s Sackler family owners to contribute nearly $4.3 billion to the settlement.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
